Regeneron-Sanofi drug succeeds mid-stage study | | (Reuters) - Regeneron Pharmaceuticals Inc and Sanofi SA said on Monday their drug to treat inflammation in the esophagus, mainly caused by food allergies, met the main goal of a mid-stage study. |
| |
Trump says he could jettison drug czar pick | | WASHINGTON (Reuters) - U.S. President Donald Trump said on Monday he would review a report that his nominee for drug czar championed a law that weakened the government's ability to fight the nation's opioid epidemic, and said he could consider jettisoning the pick. |
| |
| | |